Arp Americas »

Evolus shares owned by Arp Americas

Quarter-by-quarter ownership of Evolus (EOLS) shares owned by Arp Americas from 13F filings

Historical chart of Arp Americas investment in Evolus

Tip: Access up to 7 years of quarterly data

All positions including Evolus held by Arp Americas consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Evolus by Arp Americas

Quarter filed Position value Share count Share price at filing
2025-12-31 $178k 27k 6.65
2025-06-30 $102k 11k 9.21

More positions owned by Arp Americas

Comerica Incorporated
Janus Henderson Group Ord Shs (JHG)
Cidara Therapeutics Com New (CDTX)
Norfolk Southern (NSC)
Electronic Arts (EA)
Ceridian Hcm Hldg
Amicus Therapeutics (FOLD)
EXACT Sciences Corporation (EXAS)
Avidity Biosciences Ord (RNA)
Confluent Class A Com (CFLT)
Cadence Bank
Warner Bros Discovery Com Ser A (WBD)
Alexander & Baldwin (ALEX)
Dynavax Technologies Corp Com New (DVAX)
Heritage Commerce (HTBK)

View all positions for Arp Americas

Top funds holding Evolus

Nantahala Capital Management
BlackRock
Vanguard Group
Braidwell
Frazier Life Sciences Management
Millennium Management
Stonepine Capital Management
State Street Corporation
Geode Capital Management
D. E. Shaw & Co
Tang Capital Management
Rice Hall James & Associates
Soleus Capital Management
Schroder Investment Management Group
UBS Group

View all funds holding Evolus